Fig. 4

A Triangulation ((APD90-APD30)/APD90) for the lowest concentrations of levosimendan (0.1 µM, n = 9), milrinone (1 µM, n = 9) and isoprenaline (0.01 µM, n = 9) during hypothermia and rewarming. B Triangulation ((APD90-APD30)/APD90) for the different levosimendan concentrations (0.1 µM, 1 µM and 10 µM). C Triangulation ((APD90-APD30)/APD90) for the intermediate concentrations of levosimendan (1 µM, n = 9), milrinone (10 µM, n = 9) and isoprenaline (0.1 µM, n = 9) during hypothermia and rewarming. D Triangulation ((APD90-APD30)/APD90) for the different milrinone concentrations (1 µM, 10 µM and 100 µM). E Triangulation ((APD90-APD30)/APD90) for the highest concentrations of levosimendan (10 µM, n = 9), milrinone (100 µM, n = 9) and isoprenaline (1 µM, n = 9) during hypothermia and rewarming. F Triangulation ((APD90-APD30)/APD90) for the different isoprenaline concentrations (0.01 µM, 0.1 µM and 1 µM). A, C, E *Significant differences between levosimendan and DMSO 0.1% (n = 15), ^#significant difference between milrinone and DMSO 0.1% (n = 15), $significant difference between isoprenaline and DMSO 0.1% (n = 15). B, D, F *Significant difference between lowest and intermediate concentration, ^#significant difference between lowest and highest concentration, ^$significant difference between intermediate and highest concentration